Literature DB >> 24808019

Intensive care unit admission in multiple sclerosis: increased incidence and increased mortality.

Ruth Ann Marrie1, Charles N Bernstein2, Christine A Peschken2, Carol A Hitchon2, Hui Chen2, Randy Fransoo2, Allan Garland2.   

Abstract

OBJECTIVE: To compare the incidence of, and mortality after, intensive care unit (ICU) admission as well as the characteristics of critical illness in the multiple sclerosis (MS) population vs the general population.
METHODS: We used population-based administrative data from the Canadian province of Manitoba for the period 1984 to 2010 and clinical data from 93% of admissions to provincial high-intensity adult ICUs. We identified 5,035 prevalent cases of MS and a cohort from the general population matched 5:1 on age, sex, and region of residence. We compared these populations using incidence rates and multivariable regression models adjusting for age, sex, comorbidity, and socioeconomic status.
RESULTS: From January 2000 to October 2009, the age- and sex-standardized annual incidence of ICU admission among prevalent cohorts was 0.51% to 1.07% in the MS population and 0.34% to 0.51% in matched controls. The adjusted risk of ICU admission was higher for the MS population (hazard ratio 1.45; 95% confidence interval [CI] 1.19-1.75) than for matched controls. The MS population was more likely to be admitted for infection than the matched controls (odds ratio 1.82; 95% CI 1.10-1.32). Compared with the matched controls admitted to ICUs, 1-year mortality was higher in the MS population (relative risk 2.06; 95% CI 1.32-3.07) and was particularly elevated in patients with MS who were younger than 40 years (relative risk 3.77; 95% CI 1.45-8.11). Causes of death were MS (9.3%), infections (37.0%), and other causes (52.9%).
CONCLUSIONS: Compared with the general population, the risk of ICU admission is higher in MS, and 1-year mortality after admission is higher. Greater attention to preventing infection and managing comorbidity is needed in the MS population.
© 2014 American Academy of Neurology.

Entities:  

Mesh:

Year:  2014        PMID: 24808019      PMCID: PMC4118502          DOI: 10.1212/WNL.0000000000000495

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  25 in total

1.  The accuracy of administrative data for identifying the presence and timing of admission to intensive care units in a Canadian province.

Authors:  Allan Garland; Marina Yogendran; Kendiss Olafson; Damon C Scales; Kari-Lynne McGowan; Randy Fransoo
Journal:  Med Care       Date:  2012-03       Impact factor: 2.983

2.  National estimates of intensive care utilization and costs: Canada and the United States.

Authors:  P Jacobs; T W Noseworthy
Journal:  Crit Care Med       Date:  1990-11       Impact factor: 7.598

3.  Prevalence and incidence of ischemic heart disease in multiple sclerosis: A population-based validation study.

Authors:  Ruth Ann Marrie; Bo N Yu; Stella Leung; Lawrence Elliott; Patricia Caetano; Sharon Warren; Christina Wolfson; Scott B Patten; Lawrence W Svenson; Helen Tremlett; John Fisk; James F Blanchard
Journal:  Mult Scler Relat Disord       Date:  2013-04-02       Impact factor: 4.339

Review 4.  Multiple sclerosis as a comorbidity: a study of resource utilization and outcomes of care.

Authors:  S T Fleming
Journal:  Clin Perform Qual Health Care       Date:  1995 Jan-Mar

5.  Federal and nationwide intensive care units and healthcare costs: 1986-1992.

Authors:  N A Halpern; L Bettes; R Greenstein
Journal:  Crit Care Med       Date:  1994-12       Impact factor: 7.598

6.  Characterising aggressive multiple sclerosis.

Authors:  Suresh Menon; Afsaneh Shirani; Yinshan Zhao; Joel Oger; Anthony Traboulsee; Mark S Freedman; Helen Tremlett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2013-06-06       Impact factor: 10.154

7.  A cross-cultural comparison of critical care delivery: Japan and the United States.

Authors:  Carl A Sirio; Kimitaka Tajimi; Nobuyuki Taenaka; Yoshihito Ujike; Kazufumi Okamoto; Hirotada Katsuya
Journal:  Chest       Date:  2002-02       Impact factor: 9.410

8.  Mechanical ventilation and tracheostomy in multiple sclerosis.

Authors:  S J Pittock; B G Weinshenker; E F M Wijdicks
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

9.  What matters to seriously ill older persons making end-of-life treatment decisions?: A qualitative study.

Authors:  Terri R Fried; Elizabeth H Bradley
Journal:  J Palliat Med       Date:  2003-04       Impact factor: 2.947

Review 10.  Guidelines on critical care services and personnel: Recommendations based on a system of categorization of three levels of care.

Authors:  Marilyn T Haupt; Carolyn E Bekes; Richard J Brilli; Linda C Carl; Anthony W Gray; Michael S Jastremski; Douglas F Naylor; Maria Rudis PharmD; Antoinette Spevetz Md; Suzanne K Wedel; Mathilda Horst Md
Journal:  Crit Care Med       Date:  2003-11       Impact factor: 7.598

View more
  10 in total

1.  Burn injury and multiple sclerosis: A retrospective case-control study.

Authors:  Matthew R McCann; William F Hill; Jinhui Yan; Sarah Rehou; Marc G Jeschke
Journal:  Burns       Date:  2018-11-23       Impact factor: 2.744

2.  Critical Illness in Patients with Multiple Sclerosis: A Matched Case-Control Study.

Authors:  Anush Karamyan; Martin W Dünser; Douglas J Wiebe; Georg Pilz; Peter Wipfler; Vaclav Chroust; Helmut F Novak; Larissa Hauer; Eugen Trinka; Johann Sellner
Journal:  PLoS One       Date:  2016-05-31       Impact factor: 3.240

3.  Association between disease-modifying therapies for multiple sclerosis and healthcare utilisation on a population level: a retrospective cohort study.

Authors:  Lina Al-Sakran; Ruth Ann Marrie; David Blackburn; Katherine Knox; Charity Evans
Journal:  BMJ Open       Date:  2019-11-25       Impact factor: 2.692

4.  Disease-Modifying Drug Uptake and Health Service Use in the Ageing MS Population.

Authors:  Huah Shin Ng; Jonas Graf; Feng Zhu; Elaine Kingwell; Orhan Aktas; Philipp Albrecht; Hans-Peter Hartung; Sven G Meuth; Charity Evans; John D Fisk; Ruth Ann Marrie; Yinshan Zhao; Helen Tremlett
Journal:  Front Immunol       Date:  2022-01-13       Impact factor: 7.561

5.  Association of multiple sclerosis with mortality in sepsis: a population-level analysis.

Authors:  Lavi Oud; John Garza
Journal:  J Intensive Care       Date:  2022-07-25

6.  Emergency department use by persons with MS: A population-based descriptive study with a focus on infection-related visits.

Authors:  Jonas Graf; Huah Shin Ng; Feng Zhu; Yinshan Zhao; José Ma Wijnands; Charity Evans; John D Fisk; Ruth Ann Marrie; Helen Tremlett
Journal:  Mult Scler       Date:  2022-03-01       Impact factor: 5.855

7.  Disease-Modifying Drugs for Multiple Sclerosis and Association With Survival.

Authors:  Huah Shin Ng; Feng Zhu; Elaine Kingwell; Shenzhen Yao; Okechukwu Ekuma; Charity Evans; John D Fisk; Ruth Ann Marrie; Yinshan Zhao; Helen Tremlett
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2022-06-14

8.  Manifestations and impact of the COVID-19 pandemic in neuroinflammatory diseases.

Authors:  Seth N Levin; Shruthi Venkatesh; Katie E Nelson; Yi Li; Ines Aguerre; Wen Zhu; Karman Masown; Kathryn T Rimmer; Claudiu I Diaconu; Kaho B Onomichi; Victoria M Leavitt; Libby L Levine; Rebecca Strauss-Farber; Wendy S Vargas; Brenda Banwell; Amit Bar-Or; Joseph R Berger; Andrew D Goodman; Erin E Longbrake; Jiwon Oh; Bianca Weinstock-Guttman; Kiran T Thakur; Keith R Edwards; Claire S Riley; Zongqi Xia; Philip L De Jager
Journal:  Ann Clin Transl Neurol       Date:  2021-02-22       Impact factor: 5.430

9.  Colorectal Cancer Survival in Multiple Sclerosis: A Matched Cohort Study.

Authors:  Ruth Ann Marrie; Colleen Maxwell; Alyson Mahar; Okechukwu Ekuma; Chad McClintock; Dallasl Seitz; Patti Groome
Journal:  Neurology       Date:  2021-09-15       Impact factor: 9.910

10.  Disease-modifying drugs for multiple sclerosis and subsequent health service use.

Authors:  Huah Shin Ng; Feng Zhu; Elaine Kingwell; Yinshan Zhao; Shenzhen Yao; Okechukwu Ekuma; Lawrence W Svenson; Charity Evans; John D Fisk; Ruth Ann Marrie; Helen Tremlett
Journal:  Mult Scler       Date:  2021-12-24       Impact factor: 6.312

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.